Shurink Universe
Price upon consultation
Shurink Universe is Shurink’s second-generation device that delivers high-intensity focused ultrasound (HIFU) to different skin layers. With the dot-based Normal mode, line-based MP mode, and seven types of cartridges, it provides customized lifting treatment even for contoured areas.
Shurink Universe is Shurink’s second-generation device that delivers high-intensity focused ultrasound (HIFU) to each skin layer. With the dot-based Normal mode, line-based MP mode, and seven cartridges, customized Lifting can be performed even on contoured areas.

Recommended for
· Those concerned about fine lines on the Face and Crow's Feet · Those who want more precise Lifting than conventional Shurink · Those with reduced skin elasticity and enlarged pores · Those who want to improve uneven facial contours · Those who want V-line Lifting without disrupting daily activities
Features of Lienjang Black Shurink Universe

Point 1. Two modes
Normal mode uses a dot-type application for overall Lifting and tightening, while MP mode uses a line-type application to deliver energy to areas with thicker tissue, such as the double chin and deep cheeks.
Point 2. Customized cartridges by area
Customized treatment is available using seven cartridges and an Ultra Booster pen-type handpiece according to skin depth and contours.

Point 3. Shorter treatment time
The faster treatment speed compared to previous products reduces discomfort from pain.
Treatment Information
| Recommended frequency: At least 3 sessions at intervals of 1–3 months | Daily activities: Cleansing and makeup are possible immediately after treatment
Post-Treatment Precautions
· Please wash your face with lukewarm water for 3 days after treatment. · Temporary warmth usually disappears within 1–2 days. · Avoid saunas for approximately 2 weeks after treatment. · Avoid strenuous exercise that causes heavy sweating.
Please Note
Treatment results, duration of effect, and reactions such as swelling and redness may vary depending on individual skin condition. Whether to proceed with treatment and the treatment method will be determined through consultation with a specialist.
Medical Staffs
Chief Medical OfficerCHANG YOUNG WOO4926
DirectorOH WON JONG5516
DirectorYEO IN GWON3546
DirectorCHO SUNG HEE4056
DirectorLEE WOO JIN4720
DirectorPARK JAE WAN8840
DirectorJANG HYUNG WOOK8290
DirectorMIN JAE YOUNG4110
DirectorKYUNG JI YEON5440
DirectorKIM TAE WAN2450
DirectorSHIN HYE WON4380
DirectorKIM DONG HYUN3430
Consultation SpecialistLIENJANG BLACK7610